Literature DB >> 18218193

Preparative isolation of bufalin and cinobufagin from Chinese traditional medicine ChanSu.

Zhen Yang1, Huafei Luo, Hao Wang, Huimin Hou.   

Abstract

In this investigation, a method is developed for the isolation and purification of bufadienolides (resibufogenin, cinobufagin, and bufalin) from the Chinese traditional medicine ChanSu. The crude ChanSu extract is prepared with solvent refluxing under optimal conditions. A new chromatographic approach for separating bufadienolides utilizes silica gel column chromatography with isocratic elution using cyclohexane-acetone (5:1) as the mobile phase to separate resibufogenin, followed by reversed-phase C18 preparative HPLC column using isocratic elution of methanol-water (72:28) to separate bufalin and cinobufagin. Combining these two methods, bufalin and cinobufagin could be completely separated in high purity and recovery, and the amounts obtained were 1.9 and 3.1 g, respectively, from 500 g of ChanSu. These two compounds have been identified by mass spectrometry and 1H NMR, and their purities were quantitated by HPLC at 99% and 98%, respectively.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18218193     DOI: 10.1093/chromsci/46.1.81

Source DB:  PubMed          Journal:  J Chromatogr Sci        ISSN: 0021-9665            Impact factor:   1.618


  17 in total

1.  Bufalin promotes apoptosis of gastric cancer by down-regulation of miR-298 targeting bax.

Authors:  Hongyan Zhao; Dali Zhao; Gang Tan; Yong Liu; Liwei Zhuang; Tiefu Liu
Journal:  Int J Clin Exp Med       Date:  2015-03-15

2.  Steroid-like compounds in Chinese medicines promote blood circulation via inhibition of Na+/K+ -ATPase.

Authors:  Ronald J Y Chen; Tse-yu Chung; Feng-yin Li; Wei-hung Yang; Tzyy-rong Jinn; Jason T C Tzen
Journal:  Acta Pharmacol Sin       Date:  2010-06       Impact factor: 6.150

3.  Detecting metabolites of different transition metal-lithospermate B complexes after intravenous injection in rats.

Authors:  Ying-Jie Chen; Tse-Yu Chung; Wen-Ying Chen; Chung-Yu Chen; Maw-Rong Lee; Tzyy-Rong Jinn; Jason Tc Tzen
Journal:  Acta Pharmacol Sin       Date:  2014-07       Impact factor: 6.150

4.  Bufalin enhances the anti-proliferative effect of sorafenib on human hepatocellular carcinoma cells through downregulation of ERK.

Authors:  Yang Gao; Hua-Xing Li; Li-Tao Xu; Peng Wang; Li-Yan Xu; Lorenzo Cohen; Pei-Ying Yang; Ke Gu; Zhi-Qiang Meng
Journal:  Mol Biol Rep       Date:  2011-05-27       Impact factor: 2.316

Review 5.  Active ingredients in Chinese medicines promoting blood circulation as Na+/K+ -ATPase inhibitors.

Authors:  Ronald J Y Chen; Tzyy-rong Jinn; Yi-ching Chen; Tse-yu Chung; Wei-hung Yang; Jason T C Tzen
Journal:  Acta Pharmacol Sin       Date:  2011-02       Impact factor: 6.150

6.  Enhancing the potency of lithospermate B for inhibiting Na+/K+-ATPase activity by forming transition metal ion complexes.

Authors:  Nan-Hei Lin; Tse-Yu Chung; Feng-Yin Li; Hsin-An Chen; Jason T C Tzen
Journal:  Acta Pharmacol Sin       Date:  2013-05-20       Impact factor: 6.150

7.  Chansu inhibits the expression of cortactin in colon cancer cell lines in vitro and in vivo.

Authors:  Chun Li; Saeed M Hashimi; Siyu Cao; Ji Qi; David Good; Wei Duan; Ming Q Wei
Journal:  BMC Complement Altern Med       Date:  2015-07-02       Impact factor: 3.659

8.  Chromatographic fingerprinting analysis of Zhizhu Wan preparation by high-performance liquid chromatography coupled with photodiode array detector.

Authors:  Hui Sun; Xi Chen; Aihua Zhang; Tetsuro Sakurai; Jinzhong Jiang; Xijun Wang
Journal:  Pharmacogn Mag       Date:  2014-10       Impact factor: 1.085

9.  Identification of Na+/K+-ATPase inhibition-independent proarrhythmic ionic mechanisms of cardiac glycosides.

Authors:  Cai Hong Koh; Jianjun Wu; Ying Ying Chung; Zhenfeng Liu; Rong-Rong Zhang; Ketpin Chong; Vladimir Korzh; Sherwin Ting; Steve Oh; Winston Shim; Hai-Yan Tian; Heming Wei
Journal:  Sci Rep       Date:  2017-05-26       Impact factor: 4.379

10.  Preclinical study of cinobufagin as a promising anti-colorectal cancer agent.

Authors:  Xing-Sheng Lu; Yin-Biao Qiao; Ya Li; Bo Yang; Min-Bin Chen; Chun-Gen Xing
Journal:  Oncotarget       Date:  2017-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.